Systech has been recognized by APAC CIOOutlook Magazine as the recipient of “Top Pharma & Life Science Solution Companies,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the APAC CIOOutlook research and editorial team based on insights from an interview with Ara Ohanian.

Systech
Securing the Pharmaceutical Supply Chain with Safe, Connected and Authentic Products

Ara Ohanian, CEO

Ensuring products are safe across the supply chain:

Counterfeit or diverted drugs pose serious harm to patients. They can even be fatal. The rising incidence of pharmaceutical counterfeiting ($200B globally) has resulted in varying legislation worldwide to secure global supply chains. End-to-end product tracking and authentication from point of manufacture to point of dispensation—is essential to ensure compliance, control quality, stop revenue loss and keep people safe. Achieving this level of traceability is not easy.

The world’s leading pharmaceutical companies rely on Systech—the serialization pioneer—to secure their distribution channels. Systech uniquely combines powerful machine vision with flexible cloud-based solutions into one comprehensive platform to provide complete item transfer visibility from manufacturing through the supply chain into the patient’s hands.

Systech uniquely combines powerful machine vision with flexible cloud-based solutions into one comprehensive platform to provide complete item transfer visibility

Safeguarding consumers, brand and revenue flow:

Even with worldwide legislation in place, issues such as diversion and serial number replication continue to put patients at risk. Moving beyond serialization, Systech offers a brand-protection solution that works with the customer’s existing drug packaging. There is no need to add special inks, holograms, taggants or any other common authentication technology.

Each physical item becomes connected with a unique digital identifier—or e-Fingerprint®—that cannot be reverse engineered or duplicated. This provides non-additive, covert product security, giving trade partners the ability to confirm authenticity anytime, anywhere across the supply chain.

Connecting the physical to the digital for blockchain:

More and more companies are looking at technologies such as blockchain to leverage their new data paradigm and provide a globally distributed immutable record of their data with an unprecedented level of security. Distributed systems have no single point of failure and their scalability is huge.

While pharmaceutical trading partners may not be exchanging bitcoins for drug products, there is inherent value in blockchain technology to provide a layer of trust which is missing today. Imagine the possibilities when a product’s physical identity is connected to the digital world of blockchain with Systech.